| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | 0.006 | 0.8 |
| mRNA | trifluoperazine | CTRPv2 | pan-cancer | AAC | 0.008 | 0.8 |
| mRNA | VX-702 | GDSC1000 | pan-cancer | AAC | 0.0066 | 0.9 |
| mRNA | AUY922 | GDSC1000 | pan-cancer | AAC | 0.0067 | 0.9 |
| mRNA | BRD-K27188169 | CTRPv2 | pan-cancer | AAC | -0.01 | 0.9 |
| mRNA | BRD-K55116708 | CTRPv2 | pan-cancer | AAC | 0.0071 | 0.9 |
| mRNA | PI-103 | CTRPv2 | pan-cancer | AAC | 0.0067 | 0.9 |
| mRNA | BRD-K03536150 | CTRPv2 | pan-cancer | AAC | 0.0071 | 0.9 |
| mRNA | bid1870 | gCSI | pan-cancer | AAC | 0.017 | 0.9 |
| mRNA | manumycin A | CTRPv2 | pan-cancer | AAC | -0.0057 | 0.9 |